Combinatorial peptide libraries in drug design: lessons from venomous cone snails. 1995

B M Olivera, and D R Hillyard, and M Marsh, and D Yoshikami
Department of Biology, University of Utah, Salt Lake City 84112, USA.

Many present-day drugs are derived from compounds that are natural products, a traditional source of which is fermentation broths of microorganisms. The venoms of cone snails are a new natural resource of peptides that may have a pharmaceutical potential equivalent to those from traditional sources, particularly for developing drugs that target cell-surface receptors or ion channels. In effect, cone snails have used a combinatorial library strategy to evolve their small, highly bioactive venom peptides. The methods by which the snails have generated thousands of peptides with remarkable specificity and high affinity for their targets may provide important lessons in designing combinatorial libraries for drug development.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D008978 Mollusk Venoms Venoms from mollusks, including CONUS and OCTOPUS species. The venoms contain proteins, enzymes, choline derivatives, slow-reacting substances, and several characterized polypeptide toxins that affect the nervous system. Mollusk venoms include cephalotoxin, venerupin, maculotoxin, surugatoxin, conotoxins, and murexine. Conus Venoms,Octopus Venoms,Snail Venoms,Conus Venom,Mollusc Venoms,Mollusk Venom,Octopus Venom,Snail Venom,Venom, Conus,Venom, Mollusk,Venom, Octopus,Venom, Snail,Venoms, Conus,Venoms, Mollusc,Venoms, Mollusk,Venoms, Octopus,Venoms, Snail
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012908 Snails Marine, freshwater, or terrestrial mollusks of the class Gastropoda. Most have an enclosing spiral shell, and several genera harbor parasites pathogenic to man. Snail
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs

Related Publications

B M Olivera, and D R Hillyard, and M Marsh, and D Yoshikami
January 1988, Annual review of biochemistry,
B M Olivera, and D R Hillyard, and M Marsh, and D Yoshikami
November 2009, Applied and environmental microbiology,
B M Olivera, and D R Hillyard, and M Marsh, and D Yoshikami
November 2019, ACS omega,
B M Olivera, and D R Hillyard, and M Marsh, and D Yoshikami
December 1985, Science (New York, N.Y.),
B M Olivera, and D R Hillyard, and M Marsh, and D Yoshikami
July 1994, Bio/technology (Nature Publishing Company),
B M Olivera, and D R Hillyard, and M Marsh, and D Yoshikami
October 1995, Journal of medicinal chemistry,
B M Olivera, and D R Hillyard, and M Marsh, and D Yoshikami
September 2006, Organic & biomolecular chemistry,
B M Olivera, and D R Hillyard, and M Marsh, and D Yoshikami
May 2004, Current opinion in drug discovery & development,
B M Olivera, and D R Hillyard, and M Marsh, and D Yoshikami
April 1994, Journal of medicinal chemistry,
B M Olivera, and D R Hillyard, and M Marsh, and D Yoshikami
December 2001, Toxicon : official journal of the International Society on Toxinology,
Copied contents to your clipboard!